810P PRESERV MEL: Real-world outcomes and health-related quality of life (HRQoL) in patients receiving adjuvant nivolumab for melanoma in Belgium and Luxembourg
| Autor: | Rogiers, A., Willemot, L., McDonald, L., Van Campenhout, H., Vouk, K., Berchem, G., Jacobs, C., Rorive, A., Neyns, B. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S916-S916 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|